Skip to content

Sean Brynjelsen, President & CEO at Eton Pharmaceuticals, sold ETON on Aug 20, 2026

Data as of Oct 16

▼ SELL$456K7,342 shares at $62.12Sean Brynjelsen President & CEOETON Eton Pharmaceuticals, Inc.
Watch ETON
Traded
Aug 20, 2026
Disclosed
Aug 20, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Sean Brynjelsen, President & CEO at Eton Pharmaceuticals, sold ETON on Aug 20, 2026TRADEDDISCLOSED
ETONSimilar stocks (XLV — its sector index fund), rebased to ETON's price on the disclosure day
ETON since disclosure
−16.0%
after the sale
Similar stocks (XLV) since disclosure
+2.5%
XLV — its sector index fund

Change in closing price from Aug 20, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLSean Brynjelsen President & CEOETON Eton Pharmaceuticals, Inc.$2.8Mdisclosed Aug 20 · filed the same day
  2. ▼ SELLSean Brynjelsen President & CEOETON Eton Pharmaceuticals, Inc.$2.2Mdisclosed Aug 20 · filed the same day
  3. ▼ SELLSean Brynjelsen President & CEOETON Eton Pharmaceuticals, Inc.$562Kdisclosed Aug 20 · filed 1 day after the trade

See every trade on ETON →